Insulin Glargine (U-100) Cartridge Systems and Pens and Ranibizumab ophthalmic
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine Capsule
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine Hydrochloride
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine Injection
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine Suspension
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine Syrup
- Ranibizumab ophthalmic-Insulin Glargine (U-100) Vials
- Ranibizumab ophthalmic-Insulin Glargine (U-300) Pens
- Ranibizumab ophthalmic-Insulin glargine and lixisenatide
- Ranibizumab ophthalmic-Insulin glargine and lixisenatide Subcutaneous
- Ranibizumab ophthalmic-Insulin glargine, recombinant Subcutaneous
- Ranibizumab ophthalmic-Insulin glulisine